Help
Login
Busy
Search
eHDSI - Issues

 
Select object
 
false
Results (1 / 1)
Id Issue Status Priority Type Date Assigned To Label
406 Inconsistency with substitution description Closed Normal Change Request 2023-05-03 16:31:11 Mathias Ghys
 
Change Request Inconsistency with substitution description
Id epsos-issue-406
Status Closed
Priority Normal
Last Tracking 2023-05-03 16:31:11  by  Mathias Ghys
Current Assignee Mathias Ghys
    
Concerns
Template
false
eHDSI Substance Administration (1.3.6.1.4.1.12559.11.10.1.3.1.3.2)
/
/
Template 1.3.6.1.4.1.12559.11.10.1.3.1.3.2 (2023-04-20 15:20:58) eHDSI Substance Administration
Status Retired
/
-
/
-
Events
Tracking Closed 2023-05-03 16:31:11 : Tracking by Mathias Ghys
Assignment 2023-05-03 16:02:28 : Assigned To Mathias Ghys by Mathias Ghys
Tracking Open 2023-05-03 16:02:27 : Tracking by Mathias Ghys
Edited by mghys ( 2023-05-03 16:29:41 ) mghys ( 2023-05-03 16:31:04 )
Description
Finding:

The substitution logic description is not aligned with the implementation:

https://art-decor.ehdsi.eu/html/publication/epSOS/epsos-html-20230118T153212/tmp-1.3.6.1.4.1.12559.11.10.1.3.1.3.2-2022-12-13T144456.html

This text:
Within the epSOS-I scope the “N” code shall be interpreted as No substitution allowed excepting for the Package Size.

The presence of any other code that is not “N”, or the absence of the substitution instructions, means that also the brand name (as well as the Package Size) can be changed.

The implemented logic is:
Substitution No -> only brand name can be modified.
Substitution Yes -> brand name, package size and number of packages can be modified.

This must be reflected in the description.

Suggestion by the eP Cluster:

Therefore we suggest a new phrasing: 
  • When substitution is not allowed: The same medicinal product must be dispensed, the product name may differ when a product is marketed under different names in different countries.
  • When substitution is allowed: The product name can differ as generic substitution allows products from other manufacturers to be dispensed.
Link to JIRA issue: https://citnet.tech.ec.europa.eu/CITnet/jira/browse/EHEALTH-9775

Suggestion:

-

Further explanation:

-

    
Labels
Preview Code HTML color Display Name Description
 
 TBA 
TBA TBA To be approved
To be discussed and approved
 
 M1 
M1 M1 Milestone 1
Milestone 1 – before the EXPAND-athon 9-12 December 2015 Lisbon
 
 M2 
M2 M2 Milestone 2
Milestone 2 – final results to be delived at the end of EXPAND
 
 M3 
M3 M3 Milestone 3
Milestone 3 – end of the HL7 International Project
 
 M4 
M4 M4 Milestone 4
Milestone 4 – for consideration in the future / desiderata
 
 WJ 
WJ WJ Changes Word/JIRA
Changes in the Word Specification/Open a JIRA issue
 
 TID 
TID TID Template ID
Template-ID changes throughout the specification